Patents by Inventor Regina Geertruida Schoemaker

Regina Geertruida Schoemaker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of moxonidine for postmyocardial infarction treatment
    Patent number: 7041303
    Abstract: A method of treating myocardial damage secondary to myocardial infarction using moxonidine or a physiologically compatible salt thereof. Pharmaceutical preparations containing moxonidine and its physiologically compatible acid addition salts are suitable for use in acute myocardial infarction and/or postmyocardial infarction management. In addition to a beneficial influence, promoting recovery and/or rehabilitation, on the myocardial status following myocardial infarction, moxonidine and its physiologically compatible acid addition salts, especially when used in the management of postmyocardial infarction patients in the chronic stage, also show a preventive effect against the progression of heart failure after myocardial infarction.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: May 9, 2006
    Assignee: Solvay Pharmaceuticals GmbH
    Inventor: Regina Geertruida Schoemaker
  • Use of moxonidine for postmyocardial infarction treatment
    Publication number: 20020045633
    Abstract: A method of treating myocardial damage secondary to myocardial infarction using moxonidine or a physiologically compatible salt thereof. Pharmaceutical preparations containing moxonidine and its physiologically compatible acid addition salts are suitable for use in acute myocardial infarction and/or postmyocardial infarction management. In addition to a beneficial influence, promoting recovery and/or rehabilitation, on the myocardial status following myocardial infarction, moxonidine and its physiologically compatible acid addition salts, especially when used in the management of postmyocardial infarction patients in the chronic stage, also show a preventive effect against the progression of heart failure after myocardial infarction.
    Type: Application
    Filed: July 31, 2001
    Publication date: April 18, 2002
    Inventor: Regina Geertruida Schoemaker